Nice Mice Considering the amount of junk food I have eaten in the past week, I figured now is as good a time as any to talk about…
FDA
Gastroparesis We have all felt bloated after a meal. Usually, some classic Pepto Bismol does the trick, however, some aren’t as lucky. Gastroparesis, also referred to as delayed gastric…
Valeo Pharma Inc. (VPH.C) announced today that it has successfully entered into a Product Listing Agreement (PLA) with the Quebec Minister of Health. According to this agreement, the Company…
Medexus Pharmaceuticals Inc. (MDP.T) announced today that the U.S. Food and Drug Administration (FDA) has granted a Type A meeting to medac for treosulfan. “We have been actively working…
Protagonist Therapeutics (PTGX.Q) announced the receipt of verbal communication from the U.S. Food and Drug Administration (FDA) that the Company’s clinical studies for rusfertide have been placed on a…
Chembio Diagnostics (CEMI.Q) today announced its launch of commercial distribution of an FDA Emergency Use Authorized, patent pending, rapid point-of-care COVID-19 antigen test for use in decentralized and traditional…
PolarityTE (PTE.Q) has provided an update regarding correspondence from the U.S. Food and Drug Administration (FDA) related to the Company’s Investigational New Drug Application (IND) for SkinTE®, which was…
Medexus Pharmaceuticals (MDP.T) today announced its financial results and provided a business update for the three-month period ended June 30, 2021. “We continued to see pressure on IXINITY® ex-factory…
PharmaTher (PHRM.C) announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) for ketamine in the treatment of Amyotrophic Lateral Sclerosis (ALS), also…
Medexus Pharmaceuticals (MDP.T) announced today that medac GmbH, the Company’s licensor for treosulfan, has received a Complete Response Letter (CRL) from the Food and Drug Administration (FDA) in response…